Jump to Main Content

Wayne E. Hassay, Partner Archive

Raptiva linked to an often fatal brain infection.

Raptiva is once-a-week injection for treatment of psoriasis. It was pulled from the U.S. market on April 8, 2009. It was withdrawn because Raptiva suppresses the immune system, which increases the risk of serious infections, including a rare viral brain infection known as progressive multifocal leukoencephalopathy (PML). We are investigating...     go to full article »»

Posted on April 14, 2009 |

Let Us Help You Protect Your Assets

Have you ever stopped to consider how long you or your parents have worked to build the value of your estates? That hard work can be significantly compromised when faced with the high cost of nursing home care. Most people know they can rely on Medicaid to cover the cost...     go to full article »»

Posted on February 27, 2009 |

Bertek, UDL, and Digitek May Contain Twice the Approved Active Ingredient

Digitek, a drug used to treat heart failure and abnormal heart rhythms, has been recalled because some tablets contain twice the approved level of active ingredient. These tablets can cause serious injuries--including low blood pressure, cardiac instability, and death. Please contact us if you or a loved one has suffered...     go to full article »»

Posted on September 15, 2008 |

Gadolinium Injection Used To Improve MRI Image Can Cause An Incurable Skin Disease In People With Kidney Problems

Gadolinium is used to obtain a brighter and better image on MRI (magnetic resonance imaging) and MRA (magnetic imaging angiography) scans. In people with kidney problems it can cause an incurable disease known as NSF/NFD. NSF/NFD typically starts with swelling and tightening of the skin, frequently with red or dark...     go to full article »»

Posted on January 12, 2008 |